Its been a while since my last post here but its getting harder to find time between the 2 companies and writing grants. But one of the most interesting things I have been watching has been the roller coaster ride of the Pediatric Rare Disease priority review vouchers over a few years. The most recent one awarded to Ultragenyx will doubtless also be sold but can you predict how much for? and will it be as much as their last voucher? If I have missed any please let me know.
